Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets

NCT05046184 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

165

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder
Healthy Controls

Interventions

DRUG: Ketamine Hydrochloride
DRUG: Midazolam injection

Sponsor

University of Texas Southwestern Medical Center